SCHEMBL6418310

SCHEMBL6418310

CC(C(N)=O)N1C(=O)c2ccccc2C(C(=O)Nc2ccn(Cc3ccccc3)c2)C1c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.35
KCNA5 P22460 1/20 0.35
CYP2C19 P33261 2/20 0.34
BRS3 P32247 2/20 0.34
CYP2C9 P11712 1/20 0.34
NPC1 O15118 1/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPT P10636 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MDM2 Q00987 4/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
KCNJ6 P48051 1/20 0.32
KCNJ5 P48544 1/20 0.32
KCNJ3 P48549 1/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 1/20 0.32
CYP2D6 P10635 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6417894 0.81 UBE2M (0.46) MEN1KMT2ATACR1
SCHEMBL6417356 0.80 DRD2 (0.46) TACR1
SCHEMBL6410223 0.78 ALDH1A1 (0.42) GAABRS3HSD17B10MAPTALDH1A1
SCHEMBL6416804 0.74 TACR1 (0.34) CYP2C19CYP2C9HSD17B10MAPTALDH1A1
SCHEMBL6410783 0.73 ALDH1A1 (0.41) CYP2C19CYP2C9HSD17B10MAPTALDH1A1
SCHEMBL6411908 0.71 KCNA5 (0.43) KCNA5BRS3HSD17B10TACR1
SCHEMBL6411735 0.71 KCNA5 (0.43) KCNA5HSD17B10TSHRTACR1
SCHEMBL6418274 0.70 MAPK1 (0.51) GAANPC1HSD17B10MAPTALDH1A1
SCHEMBL6417309 0.69 ALDH1A1 (0.55) GAACYP2C19BRS3CYP2C9HSD17B10
SCHEMBL6418322 0.69 HSD17B10 (0.55) GAAKCNA5CYP2C9NPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis AXYS PHARMACEUTICALS, INC. (US) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124614-A1 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis CASP3, BAX, BAD GAA 2485/4885KCNA5 4622/4885CYP2C19 2303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.